Legend Biotech Corp - COMMON STOCK (LEGN)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
367,291,225
Total 13F shares
51,000,301
Share change
+853,660
Total reported value
$1,853,430,157
Put/Call ratio
121%
Price per share
$36.34
Number of holders
135
Value change
+$18,305,235
Number of buys
90
Number of sells
51

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q1 2022

As of 31 Mar 2022, Legend Biotech Corp - COMMON STOCK (LEGN) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,000,301 shares. The largest 10 holders included HHLR ADVISORS, LTD., BlackRock Inc., Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Capital World Investors, FEDERATED HERMES, INC., ALLIANCEBERNSTEIN L.P., BAKER BROS. ADVISORS LP, and Artisan Partners Limited Partnership. This page lists 136 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.